Variant | Gene | Type | COSMIC ID | DNA Change (Coding Nucleotide) | Exon |
---|---|---|---|---|---|
MAP2K2 copy number gain | MAP2K2 | CNV | |||
MAP2K2 copy number loss | MAP2K2 | CNV | |||
MAP2K2 any mutation | MAP2K2 | any |
MAP2K2 mutations result in constitutive ERK phosphorylation and may be associated with higher resistance to MEK inhibitors. However these inhibitors are currently undergoing clinical trials and their efficacy and/or lack of toxicity has not yet been demonstrated.
This gene is a known cancer gene.
This gene is a known cancer gene.